Ligand · SM9

SM9 · N-(2-ethoxyethyl)-N-{(2S)-2-hydroxy-3-[(5R)-2-(quinazolin-4-yl)-2,7-diazaspiro[4.5]dec-7-yl]propyl}-2,6-dimethylbenzenesulfonamide

SM9, N-(2-ethoxyethyl)-N-{(2S)-2-hydroxy-3-[(5R)-2-(quinazolin-4-yl)-2,7-diazaspiro[4.5]dec-7-yl]propyl}-2,6-dimethylbenzenesulfonamide (C31 H43 N5 O4 S, 581.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB…

Component: SM9
Formula: C31 H43 N5 O4 S
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

SM9 in 2 structures; the first of them:

3QKM · Spirocyclic sulfonamides as AKT inhibitors · SM9 A1 · binds LEU156, GLY157, LYS158, GLY159, THR160, PHE161, GLY162, LYS163 and 19 more
3QKM · Spirocyclic sulfonamides as AKT inhibitors · SM9 A1 · binds LEU156, GLY157, LYS158, GLY159, THR160, PHE161, GLY162, LYS163 and 19 more

Residues it binds most

GLU 2, THR 2, GLY 2, LYS 2, ALA 2, LEU 2, MET 2, PHE 2, ASN 2, ASP 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.